Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

Press releases published on June 2, 2026

10 hours ago

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Indeterminate GlobeNewswire

11 hours ago

CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth

Indeterminate GlobeNewswire

11 hours ago

Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer

Indeterminate GlobeNewswire

11 hours ago

Ocugen to Participate in Upcoming June Investor and Industry Conferences

Indeterminate GlobeNewswire

11 hours ago

Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Indeterminate GlobeNewswire

11 hours ago

Augustine Therapeutics to Present Late-Breaking Poster at the American Diabetes Association’s 86th Scientific Sessions

Indeterminate GlobeNewswire

11 hours ago

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

Indeterminate GlobeNewswire

11 hours ago

Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts

Indeterminate GlobeNewswire

11 hours ago

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study

Indeterminate GlobeNewswire

11 hours ago

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

Indeterminate GlobeNewswire

11 hours ago

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Indeterminate GlobeNewswire

11 hours ago

SEED Therapeutics Highlights Clinical Advancement and Broad Oncology Potential of ST-01156, an RBM39 Molecular Glue Degrader in First-in-Human in Phase 1 Studies, at ASCO 2026

Indeterminate GlobeNewswire

11 hours ago

Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy

Indeterminate GlobeNewswire

11 hours ago

Telix and United Imaging Announce Strategic Theranostics Collaboration

Indeterminate GlobeNewswire

11 hours ago

Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Indeterminate GlobeNewswire

11 hours ago

Soleo Health Acquires Realo Specialty Care Pharmacy and BluHaven Management, Expanding Footprint in Mid-Atlantic Region

Indeterminate GlobeNewswire

11 hours ago

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Indeterminate GlobeNewswire

11 hours ago

Can-Fite Reports Positive Clinical Observation in Phase 2a Pancreatic Cancer Study and Highlights Namodenoson’s RAS Signaling Inhibition Mechanism

Indeterminate GlobeNewswire

11 hours ago

Digital World Industry to Reach $726.7 Billion by 2030, Driven by Quantum Sensing and AI Commercialization

Indeterminate GlobeNewswire

11 hours ago

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

Indeterminate GlobeNewswire